![Philippe Calais](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Philippe Calais
Directeur Général chez
TRANSCODE THERAPEUTICS, INC.
Fortune : 4 $ au 31/08/2026
Profil
Philippe P.
Calais is the founder of Phileas Pharma, Inc., founded in 2019, serving as Chairman.
Current jobs include President, Chief Executive Officer & Director at MatriSys Bioscience, Inc.; Executive Chairman & Chief Executive Officer at TransCode Therapeutics, Inc. since 2025; and Professor at Florida Atlantic University since 2019.
Former jobs include President, Chief Executive Officer & Director at Ambrilia Biopharma, Inc. (2008–2009); President & Chief Executive Officer at Univalor, Inc. (2011–2012); President & Chief Executive Officer at Isarna Therapeutics BV (2012–2018); Chairman at Neurochem (International) Ltd. (2003–2007); Director at CohBar, Inc. (2019–2020); Lead Independent Director at Adhera Therapeutics, Inc. (2017–2018); Director at Medpharmgene, Inc. (2011–2012); Director at Autotelic, Inc. (2016–2018); Director at Cite Des Biotechs De Laval (2002–2012); Director at Cognisense (2010–2012); President-Global Business at BELLUS Health, Inc. (2003–2007); Head-Global Strategic Marketing Unit at Hoffmann-La Roche, Inc.; and General Manager at Servier Canada, Inc. (2000–2002).
Education includes undergraduate studies at Université Pierre et Marie Curie and both undergraduate and doctorate degrees from Université François-Rabelais de Tours.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 28/05/2026 | 2 ( 0 % ) | 4 $ | 31/08/2026 |
Postes actifs de Philippe Calais
| Sociétés | Poste | Début |
|---|---|---|
| TRANSCODE THERAPEUTICS, INC. | Directeur Général | 06/10/2025 |
Phileas Pharma, Inc. | Fondateur | 01/05/2019 |
MatriSys Bioscience, Inc.
 MatriSys Bioscience, Inc. BiotechnologyHealth Technology Develops rational micro biome therapies | Directeur Général | - |
Florida Atlantic University
 Florida Atlantic University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/05/2019 |
Anciens postes connus de Philippe Calais
| Sociétés | Poste | Fin |
|---|---|---|
| COHBAR | Directeur Général | 15/05/2019 |
Autotelic, Inc.
 Autotelic, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapeutics drugs | Directeur/Membre du Conseil | 01/06/2018 |
Isarna Therapeutics BV
 Isarna Therapeutics BV Financial ConglomeratesFinance Functions as an investment holding company | Directeur Général | 01/06/2018 |
| ADHERA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 02/05/2018 |
Medpharmgene, Inc.
 Medpharmgene, Inc. Miscellaneous Commercial ServicesCommercial Services Provides commercial physical research services | Directeur/Membre du Conseil | 01/02/2012 |
Formation de Philippe Calais
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
57
Relations au 1er degré
19
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
BELLUS Health, Inc.
 BELLUS Health, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for the treatment of refractory chronic disease | Health Technology |
CohBar, Inc.
 CohBar, Inc. BiotechnologyHealth Technology Develops biotechnology products that intends to treat age-related diseases through the discovery of novel mitochondrial-derived peptides | Health Technology |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
Florida Atlantic University
Florida Atlantic University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ambrilia Biopharma, Inc.
 Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel treatments for viral diseases and cancer | Health Technology |
Université Pierre et Marie Curie
 Université Pierre et Marie Curie Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université François-Rabelais de Tours
 Université François-Rabelais de Tours Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neurochem (International) Ltd.
 Neurochem (International) Ltd. Miscellaneous Commercial ServicesCommercial Services Provides licensing and partnering activities | Commercial Services |
Servier Canada, Inc.
 Servier Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for cardiology, diabetes, depression, venous disease and menopause | Health Technology |
Univalor, Inc.
 Univalor, Inc. Miscellaneous Commercial ServicesCommercial Services Univalor, Inc. engages in the provision of research and development services. The company was founded on April 27, 2001 and is headquartered in Montréal, Canada. | Commercial Services |
Adhera Therapeutics, Inc.
 Adhera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes hypertensive drugs | Health Technology |
Medpharmgene, Inc.
Medpharmgene, Inc. Miscellaneous Commercial ServicesCommercial Services Provides commercial physical research services | Commercial Services |
Autotelic, Inc.
Autotelic, Inc. Pharmaceuticals: MajorHealth Technology Manufactures therapeutics drugs | Health Technology |
MatriSys Bioscience, Inc.
MatriSys Bioscience, Inc. BiotechnologyHealth Technology Develops rational micro biome therapies | Health Technology |
TransCode Therapeutics, Inc.
 TransCode Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes diagnostics and therapeutics for the detection and treatment of cancer | Health Technology |
Phileas Pharma, Inc. | |
Isarna Therapeutics BV
Isarna Therapeutics BV Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Cite Des Biotechs De Laval | |
Cognisense |
